BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33370249)

  • 21. Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma.
    Wang P; Wang X; Zheng L; Zhuang C
    Front Genet; 2020; 11():540186. PubMed ID: 33133142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer.
    Ren S; Xiao Y; Wang H; Zhao L; Li H; Wei L; Huang Y; Liu H
    Transl Cancer Res; 2023 Aug; 12(8):2033-2047. PubMed ID: 37701104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database.
    Zhou J; Wang J; Hong B; Ma K; Xie H; Li L; Zhang K; Zhou B; Cai L; Gong K
    Aging (Albany NY); 2019 Mar; 11(6):1633-1647. PubMed ID: 30877265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
    Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C
    Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene signature and prognostic merit of M6a regulators in colorectal cancer.
    Zhang J; Cheng X; Wang J; Huang Y; Yuan J; Guo D
    Exp Biol Med (Maywood); 2020 Sep; 245(15):1344-1354. PubMed ID: 32605475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
    Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
    Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Cancer Genome Atlas (TCGA) based m
    Liu J; Sun G; Pan S; Qin M; Ouyang R; Li Z; Huang J
    Bioengineered; 2020 Dec; 11(1):759-768. PubMed ID: 32631107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a m
    Chen J; Yu K; Zhong G; Shen W
    Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer.
    Wang J; Lin H; Zhou M; Xiang Q; Deng Y; Luo L; Liu Y; Zhu Z; Zhao Z
    Future Oncol; 2020 Oct; 16(30):2421-2432. PubMed ID: 32687727
    [No Abstract]   [Full Text] [Related]  

  • 32. The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
    Xu D; Shao J; Song H; Wang J
    Biomed Res Int; 2020; 2020():9502560. PubMed ID: 32596399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
    Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
    Front Oncol; 2020; 10():718. PubMed ID: 32547941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of pathology-specific regulators of m
    Li N; Zhan X
    EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copy number variation analysis of m
    Wang X; Yu J; Chen J; Hou Y; Du Z; Huang H; Tang S; Han Y; Ding C; Xue Z
    Cancer Med; 2021 Nov; 10(21):7804-7815. PubMed ID: 34668652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer.
    Zhu W; Zhao L; Kong B; Liu Y; Zou X; Han T; Shi Y
    Ann Transl Med; 2022 Jan; 10(2):59. PubMed ID: 35282121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.